本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tango Therapeutics Inc.

6.28
+0.35005.90%
成交量:89.10万
成交额:552.43万
市值:6.81亿
市盈率:-5.21
高:6.40
开:5.91
低:5.83
收:5.93
数据加载中...
2025/06/06

重要事件披露

Form 8-K - Current report
2025/05/19

SEC问询函

Form CORRESP - Correspondence
2025/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/12

重要事件披露

Form 8-K - Current report
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/20

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/28

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities